Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Features
Sort By
Newest First
1 / 5
1 / 5
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06
Oct 11, 2022
mRNA
Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-02
Oct 11, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03
Aug 09, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06
Jul 02, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04
Jun 24, 2022
Quantum Computing
Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-10
Jun 24, 2022
Column: Technology
mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-02
Mar 23, 2022
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-05
Mar 18, 2022
Mesenchymal Stem Cells
The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-21-NI-01
Mar 12, 2022
Feature Story
Wearable Technology: Innovation, Adherence, and Clinical Outcomes
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-002
Dec 09, 2020
Feature Story
Wearable Technology: Targeting a Range of Uses and Indications
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-003
Dec 09, 2020
Feature Story
Wearable Technology: Their Future in Clinical Trials and the Real World
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-004
Dec 09, 2020
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-002
Sep 29, 2020
Feature Story
The Growing Importance of Local Manufacturing and Nearby Outsourcing Partners
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-003
Sep 29, 2020
Feature Story
Rethinking the Global Pharmaceutical Supply Chain Post-COVID-19
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-004
Sep 29, 2020
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
Nigel Walker
Nice Insight
PAP-Q2-20-NI-001
Jul 01, 2020
Molecules
Molecules that Changed Medicine
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-002
Jul 01, 2020
Coping with COVID-19
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-004
Jul 01, 2020
Capacity Expansion
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility
MilliporeSigma
PR-M04-20-NI-032-1596
Apr 23, 2020
COVID-19
COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAO-Q2-20-NI-001
Apr 07, 2020
